Parsons Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parsons Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Hold	2,755	–	–	0.02%	392
2025 Q4	$336K	Hold	2,755	–	–	0.02%	378
2025 Q3	$276K	Hold	2,755	–	–	0.02%	404
2025 Q2	$228K	Hold	2,755	–	–	0.01%	418
2025 Q1	$223K	Hold	2,755	–	–	0.01%	411
2024 Q4	$248K	Buy	2,755 +75	+3%	+$7.27K	0.01%	404
2024 Q3	$265K	Hold	2,680	–	–	0.02%	399
2024 Q2	$248K	Hold	2,680	–	–	0.02%	404
2024 Q1	$254K	Buy	2,680 +30	+1%	+$2.78K	0.02%	398
2023 Q4	$237K	Buy	+2,650	New	+$197K	0.02%	399
2023 Q3	–	Sell	-2,650	Closed	-$220K	–	432
2023 Q2	$220K	Hold	2,650	–	–	0.02%	401
2023 Q1	$202K	Hold	2,650	–	–	0.02%	409
2022 Q4	$220K	Hold	2,650	–	–	0.02%	396
2022 Q3	$210K	Buy	+2,650	New	+$223K	0.02%	395
2021 Q3	–	Sell	-1,550	Closed	-$210K	–	434
2021 Q2	$210K	Sell	1,550 -65	-4%	-$8.55K	0.02%	399
2021 Q1	$219K	Buy	+1,615	New	+$242K	0.02%	389

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parsons Capital Management's XBI Position: Q1 2026 in Review

Parsons Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 2,755 shares worth $352K. The position accounts for 0.02% of the portfolio, ranked #392.

Parsons Capital Management first reported a position in XBI in Q1 2021 and has held it in 16 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Parsons Capital Management held 2,755 shares of State Street SPDR S&P Biotech ETF worth $352K as of Q1 2026.
Parsons Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Parsons Capital Management's portfolio in Q1 2026, its #392 holding.
Parsons Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 16 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.